Dr. Andrew Srisuwananukorn, The Ohio State University, will join us to discuss and answer your questions related to MF and Pre-fibrotic MF.

If you have a myeloproliferative neoplasm including myelofibrosis, polycythemia vera, or essential thrombocythemia, and French is your first language, you may have difficulty understanding the medical team you see in France or the US, or other countries across the globe.

This webinar offers a unique opportunity to hear from an MPN specialist from France who can help you better understand your diagnosis. Please join us for this webinar with Dr. Jean-Jacques Kiladjian, Paris Diderot University/Saint Louis Hospital, who will explain MPNs and answer your questions in French and English.

Si vous souffrez d’une néoplasie myéloproliférative (NMP), notamment la myélofibrose, la polyglobulie de Vaquez ou la thrombocytémie essentielle, et que le français est votre langue maternelle, vous pourriez rencontrer des difficultés à comprendre l’équipe médicale que vous consultez en France, aux États-Unis ou dans d’autres pays du monde.

Ce webinaire offre une occasion unique d’écouter un spécialiste des NMP venant de France, qui pourra vous aider à mieux comprendre votre diagnostic. Rejoignez-nous pour ce webinaire animé par le Dr Jean-Jacques Kiladjian, de l’Université Paris Cité / Hôpital Saint-Louis, qui expliquera les NMP et répondra à vos questions en français et en anglais.

Drs. Nicole Kucine, Weill Cornell, and Linda Resar, Johns Hopkins, will join us to discuss the new findings in pediatric and young adult MPNs and address the complications with those age groups.

Dr. Aaron Gerds, Cleveland Clinic, will join us.

Dr. Gaby Hobbs, Mass General, will discuss symptoms you may experience as an MPN patient and ways to address and manage them. Questions are welcomed.

Dr. Raajit Rampal, Memorial Sloan Kettering, will discuss the intricacies of analyzing your blood work and what it means. Questions are welcomed.

Dr. Orly Leiva, a fellow at the University of Chicago, joins us to discuss the cardiac risk associated with MPN patients and how you can help your cardiac health.